bindarit has been researched along with Diabetes Mellitus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Guan, M; Huang, X; Kuang, S; Lin, Z; Qin, W; Shen, Z; Xu, HHK; Zhang, M | 1 |
1 other study(ies) available for bindarit and Diabetes Mellitus
| Article | Year |
|---|---|
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties.
Topics: Chemokine CCL2; Diabetes Mellitus; Humans; Indazoles; Macrophages; Monocytes; Periodontitis; Propionates | 2021 |